Sherzod Pardaboevich Abdullaev

13PUBLICATIONS
59CO-AUTHORS
Predictive and prognostic markersGene and molecular therapyBiologically active moleculesCancer geneticsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|May 13, 2026
Impact of Pharmacogenetic Markers on the Efficacy of Neoadjuvant FLOT Chemotherapy in Patients with Gastric and Gastroesophageal Junction Adenocarcinoma.

|Jan 27, 2026
Genetic Markers of Methotrexate Treatment Failure in Psoriasis.

Maria N Vikhreva, Lavrenty G Danilov, Andrey A Martynov

|Nov 27, 2025
An Investigational Study on the Role of ADME Agents' Genetic Variation on DD217 Pharmacokinetics and Safety Profile.

Dmitry A Sychev, Sherzod P Abdullaev, Anastasia V Rudik

|Nov 27, 2025
Towards Personalized Chemotherapy in Gastrointestinal Cancers: Prospective Analysis of Pharmacogenetic Variants in a Russian Cohort.

Denis Fedorinov, Vladimir Lyadov, Marina Lyadova

|Oct 29, 2025
Impact of Xenobiotic Detoxification Gene Polymorphisms on Steady-State Plasma Concentrations of Apixaban and the Development of Hemorrhagic Complications in Older Patients with Non-Valvular Atrial Fibrillation.

Andrey P Kondrakhin, Sherzod P Abdullaev, Ivan V Sychev

|Aug 27, 2025
Genetic Modulation of Silodosin Exposure and Efficacy: The Role of CYP3A4, CYP3A5, and UGT2B7 Polymorphisms in Benign Prostatic Hyperplasia Management.

Shokhrukh P Abdullaev, Maksim N Shatokhin, Pavel O Bochkov

Pageof 3

Frequent Collaborators

11 joint publications

Dmitry Sychev

6 joint publications

Anastasiia Kachanova

5 joint publications

Karin Mirzaev

4 joint publications

Zhannet Sozaeva